Literature DB >> 21690207

Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.

Audrey Doublier1, Delphine Farlay, Mohamed T Khebbab, Xavier Jaurand, Pierre J Meunier, Georges Boivin.   

Abstract

OBJECTIVE: To investigate interactions between strontium (Sr) and bone mineral and its effects on mineralization in osteoporotic women treated long-term with Sr ranelate (SrRan).
DESIGN: In this study, 34 iliac bone biopsies were analyzed after 2, 12, 24, 36, 48, and 60 months of treatment with SrRan.
METHODS: Sr global distribution was analyzed by X-ray cartography and the percentage of bone area containing Sr was calculated in the bone samples. The focal distribution of Sr in all bone samples was investigated by X-ray microanalysis. The degree of mineralization was assessed by quantitative microradiography.
RESULTS: Absent from old bone formed before the beginning of treatment, Sr was exclusively present in bone formed during this treatment with a much higher focal Sr content in new bone structural units than in old ones. A progressive increase in the extent of areas containing Sr was observed during treatment. The focal bone Sr content in recently formed bone was constant over treatment. Secondary mineralization was maintained at a normal level during treatment.
CONCLUSION: Thus, the quality of bone mineralization (density and heterogeneity at tissue level) was preserved after a long-term treatment with SrRan.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690207     DOI: 10.1530/EJE-11-0415

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

Review 1.  Bone quality and bone strength: benefits of the bone-forming approach.

Authors:  Giovanni Iolascon; Laura Frizzi; Gioconda Di Pietro; Annarita Capaldo; Fabrizio Luciano; Francesca Gimigliano
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

Review 2.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

3.  A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis.

Authors:  Luisella Cianferotti; Federica D'Asta; Maria Luisa Brandi
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-06       Impact factor: 5.346

Review 4.  Therapy for patients with CKD and low bone mineral density.

Authors:  Susan M Ott
Journal:  Nat Rev Nephrol       Date:  2013-10-08       Impact factor: 28.314

5.  Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women.

Authors:  A Doublier; D Farlay; X Jaurand; R Vera; G Boivin
Journal:  Osteoporos Int       Date:  2012-10-30       Impact factor: 4.507

Review 6.  Changes in the degree of mineralization with osteoporosis and its treatment.

Authors:  Paul Roschger; Barbara Misof; Eleftherios Paschalis; Peter Fratzl; Klaus Klaushofer
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 7.  Strontium Functionalization of Biomaterials for Bone Tissue Engineering Purposes: A Biological Point of View.

Authors:  Giorgia Borciani; Gabriela Ciapetti; Chiara Vitale-Brovarone; Nicola Baldini
Journal:  Materials (Basel)       Date:  2022-02-25       Impact factor: 3.623

Review 8.  The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment.

Authors:  Barbara Kołodziejska; Natalia Stępień; Joanna Kolmas
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.